Skip to content

Transcranial magnetic stimulation was used to treat attention disorders of post-stroke: A research on the structure and function of multi-modal functional nuclear magnetic field

Transcranial magnetic stimulation was used to treat attention disorders of post-stroke: A research on the structure and function of multi-modal functional nuclear magnetic field

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012520
Enrollment
Unknown
Registered
2017-08-31
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:placebo stimulus

Sponsors

Guangxi Jiangbin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. With cerebral infarctionor cerebral hemorrhage. Diagnosis was made following the standards for stroke in diagnostic criteria for cerebrovascular diseases defined in the Fourth National Conference on Cereberavascular Diseases in 1995 . Further verification was made by head CT or MRI scan; 2. Neuropsychological scale and ANT test attention disorder; 3. Aged from 25 to 70 years old; 4. Condition is steady, staged as IV ccording to Brunnstrom staging, to complete the scale test, a certain expression and communication skills; 5. Well informed and signing written consent.

Exclusion criteria

Exclusion criteria: 1. Severe mental disorders, verbal or cognitive impairment, visual or auditory impairment; 2. Nearly a month, patients underwent the treatment of attention disorders; 3. Having history of epilepsy,Serious cardiovascular disease, such as heart disease; 4. Major organs such as liver, lung and kidney are severely impaired or depleted,Concurrent tumors or cancer; 5. The family or the patient do not agree to participate in the trial.

Design outcomes

Primary

MeasureTime frame
ANT;MoCA;VFT;MRI, fMRI, DTI;

Countries

China

Contacts

Public ContactJiang Wenyu

Guangxi Jiangbin Hospital

wenyuj4411@sina.com+86 13807819809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026